Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.11.2023 | Case report

Ferric carboxymaltose

Hypophosphataemia: 7 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Chu Z, et al. Incidence and predictors of hypophosphataemia after ferric carboxymaltose use-A 3-year experience from a single institution in Singapore. British Journal of Haematology 202 : 1199-1204, No. 6, Sep 2023. Available from: URL: http://doi.org/10.1111/bjh.18979 Chu Z, et al. Incidence and predictors of hypophosphataemia after ferric carboxymaltose use-A 3-year experience from a single institution in Singapore. British Journal of Haematology 202 : 1199-1204, No. 6, Sep 2023. Available from: URL: http://​doi.​org/​10.​1111/​bjh.​18979
Metadaten
Titel
Ferric carboxymaltose
Hypophosphataemia: 7 case reports
Publikationsdatum
01.11.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-49557-6

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

AZD-1222

Case report

Diclofenac

Case report

Maraviroc

Case report

Sodium chloride

Case report

Antineoplastics